BG

Bellevue Group Portfolio holdings

AUM $4.54B
1-Year Est. Return 22.5%
This Quarter Est. Return
1 Year Est. Return
+22.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.07B
AUM Growth
-$1.54B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
187
New
Increased
Reduced
Closed

Top Buys

1
+$58.1M
2
+$41.4M
3
+$28.1M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$25.4M
5
CLDX icon
Celldex Therapeutics
CLDX
+$24.9M

Top Sells

1
+$98M
2
+$85.7M
3
+$47.7M
4
BMY icon
Bristol-Myers Squibb
BMY
+$46.5M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$42.9M

Sector Composition

1 Healthcare 98.26%
2 Industrials 0.38%
3 Energy 0.03%
4 Communication Services 0.01%
5 Technology 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$362M 5.12%
9,776,528
-141,545
2
$350M 4.94%
933,803
-19,435
3
$331M 4.69%
1,176,136
-304,117
4
$277M 3.92%
2,844,305
-179,146
5
$225M 3.19%
1,577,351
-61,998
6
$211M 2.98%
2,773,377
-74,023
7
$191M 2.7%
3,349,379
-80,240
8
$183M 2.58%
909,348
+289,280
9
$171M 2.42%
1,573,807
-49,120
10
$155M 2.19%
302,044
-3,657
11
$154M 2.18%
1,058,186
-171,377
12
$143M 2.03%
3,850,171
-63,776
13
$143M 2.02%
917,907
+162,926
14
$131M 1.85%
2,313,852
+264,647
15
$101M 1.42%
208,500
-203,137
16
$96.1M 1.36%
1,010,627
+97,842
17
$96M 1.36%
2,973,178
-79,226
18
$95M 1.34%
477,634
+37,409
19
$92.3M 1.3%
410,633
+7,867
20
$91.2M 1.29%
8,796,538
+477,824
21
$90.1M 1.27%
4,062,792
-66,500
22
$89.4M 1.26%
2,124,276
-54,977
23
$88M 1.24%
3,550,086
-26,400
24
$85.4M 1.21%
1,139,455
-11,704
25
$84.6M 1.2%
342,982
-63,333
1
2 3 4 5